Skip to main content
OpenTrials
Completed

NCT Number: NCT04834726

COVID-19 Vaccine Text Outreach

This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

About this study

This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims:

Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a defined group of Penn Medicine in a way that advances equity.

Aim 2: To offer different scheduling workflows through text messaging that might increase uptake and reduce disparities.

Aim 3: To compare the equity and efficiency of different messages informed by behavioral science, including PCP endorsement, opt-out framing, and scarcity.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)

Exclusion criteria

  • Patients who have completed any dose of the vaccine at Penn Medicine, are currently scheduled to receive the vaccine, have externally documented vaccination records, or have previously received text-message based vaccine outreach.

Treatment and study plan

Opt-In (Call-Back)

Behavioral

Messaging will include a prompt to agree to scheduling. If patient agrees, the access center will call these patients back to schedule, calling up to 3 times.

Opt-in (In-Bound)

Behavioral

Messaging will include a prompt to agree to scheduling followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.

Standard message

Behavioral

The message describes that the patient is eligible for the COVID vaccine.

Clinician Endorsement

Behavioral

The message will describe an endorsement from the provider to get the vaccination.

Scarcity

Behavioral

The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine.

Opt-out framing

Behavioral

This will highlight that a vaccine is reserved for the patient, implying that they need to opt-out.

phone call

Behavioral

The access center will call these patients to schedule their vaccine appointment. These patients will not receive text messaging.

Primary outcomes

  1. Dose 1 Completion

    Time frame: 1 month

    Percentage of patients who complete the first dose of the COVID vaccine within 1 month of initial outreach

Secondary outcomes

  1. Dose 1 Completion

    Time frame: 2 months

    Percentage of patients who complete the first dose of the COVID vaccine within 2 months of initial outreach

  2. Vaccine Completion

    Time frame: 2 months

    Percentage of patients who complete the vaccination process within 2 months of initial outreach

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Official study title

Pragmatic Trial of COVID Vaccine Text Outreach Interventions

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 8, 2021
Registry last updated
Mar 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.